Suchergebnisse - "Maartens, Gary"

PubPharm (96)

1

Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral Therapy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2024

von van Heerden, J. | Meintjes, G. | Barr, D. | +7

2

Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Brown, T. | Tang, L. | Omar, S. | +10

3

HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy : a collaborative cohort analysis

enthalten in: The lancet. HIV | 2023

von Loosli, T. | Hossmann, S. | Ingle, S. | +15

UpdateOf: medRxiv. 2023 Apr 05;:. - PMID 37066200

4

Life years lost associated with mental illness : A cohort study of beneficiaries of a South African medical insurance scheme

enthalten in: Journal of affective disorders | 2023

von Ruffieux, Y. | Wettstein, A. | Maartens, G. | +11

UpdateOf: medRxiv. 2023 Feb 02;:. - PMID 36711937

5

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB) : a phase 2, non-comparative, randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Griesel, R. | Zhao, Y. | Simmons, B. | +6

CommentIn: Lancet HIV. 2023 Jul;10(7):e422-e423. - PMID 37230100

6

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans

enthalten in: Pharmacogenetics and genomics | 2023

von Mateza, S. | Bradford, Y. | Maartens, G. | +7

7

Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV

enthalten in: Pharmacogenetics and genomics | 2023

von Cindi, Z. | Kawuma, A. | Maartens, G. | +10

8

Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy : A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Zhao, Y. | Griesel, R. | Omar, Z. | +6

9

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis : The LASER-TBM Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Davis, A. | Wasserman, S. | Stek, C. | +29

10

Drug-drug interaction between rifabutin and dolutegravir : A population pharmacokinetic model

enthalten in: British journal of clinical pharmacology | 2023

von Kawuma, A. | Wasmann, R. | Dooley, K. | +2

CommentIn: Br J Clin Pharmacol. 2023 Jul;89(7):2329-2331. - PMID 37077127

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]